Literature DB >> 3047604

Obstetrical concerns of epidermolysis bullosa.

T Price1, V L Katz.   

Abstract

Epidermolysis bullosa is a group of autosomally inherited diseases involving skin breakdown of varying degrees and severity. Prenatal diagnosis and evaluation of these diseases is reviewed although pregnancy is not generally adversely affected by these diseases. Labor and delivery practices must be altered for the management of these patients. The obstetrical team must pay careful attention to adhesive dressings and anesthetic devices. Minor trauma may lead to severe lesions.

Entities:  

Mesh:

Year:  1988        PMID: 3047604     DOI: 10.1097/00006254-198808000-00002

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  4 in total

Review 1.  Connective tissue and related disorders and preterm birth: clues to genes contributing to prematurity.

Authors:  E A Anum; L D Hill; A Pandya; J F Strauss
Journal:  Placenta       Date:  2009-01-18       Impact factor: 3.481

2.  Retrospective evidence on outcomes and experiences of pregnancy and childbirth in epidermolysis bullosa in Australia and New Zealand.

Authors:  Lizbeth R A Intong; S Deanne Choi; Alexa Shipman; Yong C Kho; Shelley J E Hwang; Lesley M Rhodes; Judie R Walton; Michael G Chapman; Dédée F Murrell
Journal:  Int J Womens Dermatol       Date:  2015-02-18

3.  Retrospective evidence on outcomes and experiences of pregnancy and childbirth in epidermolysis bullosa in Australia and New Zealand.

Authors:  Lizbeth R A Intong; S Deanne Choi; Alexa Shipman; Yong C Kho; Shelley J E Hwang; Lesley M Rhodes; Judie R Walton; Michael G Chapman; Dédée F Murrell
Journal:  Int J Womens Dermatol       Date:  2017-02-16

4.  Recommendations on pregnancy, childbirth and aftercare in epidermolysis bullosa: a consensus-based guideline.

Authors:  D T Greenblatt; E Pillay; K Snelson; R Saad; M Torres Pradilla; S Widhiati; A Diem; C Knight; K Thompson; N Azzopardi; M Werkentoft; Z Moore; D Patton; K M Mayre-Chilton; D F Murrell; J E Mellerio
Journal:  Br J Dermatol       Date:  2021-11-25       Impact factor: 11.113

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.